Literature DB >> 16275981

Editorial: germline variants within RET: clinical utility or scientific playtoy?

Frank Weber, Charis Eng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16275981     DOI： 10.1210/jc.2005-2030

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

Review 1.  Molecular genetics of thyroid cancer.

Authors:  Maha Rebaї; Ahmed Rebaї
Journal:  Genet Res (Camb)       Date:  2016-05-13       Impact factor: 1.588

2.  Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism.

Authors:  M Rotondi; T Ercolino; R Fonte; M S Lagonigro; P Leporati; L Villani; L La Manna; M Mannelli; L Chiovato
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

3.  Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility.

Authors:  Rodrigo A Toledo; Roxanne Hatakana; Delmar M Lourenço; Susan C Lindsey; Cleber P Camacho; Marcio Almeida; José V Lima; Tomoko Sekiya; Elena Garralda; Michel S Naslavsky; Guilherme L Yamamoto; Monize Lazar; Osorio Meirelles; Tiago J P Sobreira; Maria Lucia Lebrao; Yeda A O Duarte; John Blangero; Mayana Zatz; Janete M Cerutti; Rui M B Maciel; Sergio P A Toledo
Journal:  Endocr Relat Cancer       Date:  2014-11-25       Impact factor: 5.678

Review 4.  Personalized medicine: caught between hope, hype and the real world.

Authors:  Marc Dammann; Frank Weber
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

5.  Variability in Medullary Thyroid Carcinoma in RET L790F Carriers: A Case Comparison Study of Index Patients.

Authors:  Jes Sloth Mathiesen; Søren Grønlund Nielsen; Åse Krogh Rasmussen; Katalin Kiss; Karin Wadt; Anne Pernille Hermann; Morten Frost Nielsen; Stine Rosenkilde Larsen; Klaus Brusgaard; Anja Lisbeth Frederiksen; Christian Godballe; Maria Rossing
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-28       Impact factor: 5.555
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.